Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043381 · ClinicalTrials.gov registry record · Phase 3
Decitabine Versus Supportive Care in Adults With Advanced-stage MDS
A Phase 3 study, sponsored by Astex Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
NCT00043381 is a Phase 3 study that has completed, run by Astex Pharmaceuticals. The registered enrollment target is 160 participants.
The verdict
NCT00043381, a Phase 3 study, has completed, sponsored by Astex Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
Study Summary
To compare the safety and efficacy profiles of decitabine to those of supportive care in adults with advanced-stage myelodysplastic syndrome (MDS)
Interventions
- DRUG decitabine (5-aza-2'deoxycytidine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2001-04 |
| Est. Completion | 2003-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00043381
The ClinicalTrials.gov registry entry for NCT00043381 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astex Pharmaceuticals, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which decitabine (5-aza-2'deoxycytidine) is the first listed.
NCT00043381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00043381 about?
NCT00043381 is a clinical study titled "Decitabine Versus Supportive Care in Adults With Advanced-stage MDS". To compare the safety and efficacy profiles of decitabine to those of supportive care in adults with advanced-stage myelodysplastic syndrome (MDS)
What is the current status of trial NCT00043381?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2001-04. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00043381?
The interventions under investigation include: decitabine (5-aza-2'deoxycytidine) (DRUG).
Who is sponsoring clinical trial NCT00043381?
This trial is sponsored by Astex Pharmaceuticals, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.